Send feedback

INF2 p.Pro1069=

c.3207A>C · rs1128840 · VCV261617

Benign/Likely benign Multiple submitters
Classification
Benign/Likely benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 14 submitters
gnomAD v4.1
Common
common (popmax 90.8%, eas) — too common for a highly-penetrant pathogenic allele
Conditions
2
focal segmental glomerulosclerosis 5

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP -6GERP -9.6
Overall
CADD0.286PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 90.8% East Asian · 39,775/43,800 alleles
Filtering AF 90.1% ClinGen BA1/BS1 input FAF95, joint · FAF99 89.8%
Overall 56.4% 900,291/1,595,520 alleles · common exomes 810,008/1,443,394 · genomes 90,283/152,126 · joint denominator
Ancestry group Frequency 1 in
East Asiangrpmax 90.8% 1
Admixed American 68.4% 1
African / African-American 64.3% 2
South Asian 61.6% 2
Middle Eastern 59.1% 2
Remaining individualsnot grpmax-eligible 57.8% 2
Ashkenazi Jewishnot grpmax-eligible 57.4% 2
European (non-Finnish) 53.7% 2
Finnishnot grpmax-eligible 53.1% 2
Amishnot grpmax-eligible 53.1% 2

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
INF2
Protein
p.Pro1069=
Coding
c.3207A>C
MANE Select
NM_022489
dbSNP
rs1128840
Type
single nucleotide variant
Location
chr14:104714369 (GRCh38)
Gene constraint
LOEUF 0.526 · pLI 0.33 · ClinGen HI 0/3 (gnomAD)
Structure
AlphaFold pLDDT 67.34 · 10 PDB
Residue 1069
the 'disordered' region
Full INF2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/inf2-p-pro1069 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown